Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,234 | -14,487 | -8,573 | -5,724 | -3,200 |
| Accounts payable and accrued liabilities | 241 | 346 | -52 | -232 | 483 |
| Other Working Capital | -1,223 | 657 | 392 | 73 | 701 |
| Other Operating Activity | 3,194 | 4,351 | 870 | 264 | -459 |
| Operating Cash Flow | $-3,022 | $-9,132 | $-7,363 | $-5,619 | $-2,475 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 46,744 | 46,648 | 46,674 | N/A |
| Other Financing Activity | 5 | 0 | 95 | 95 | 3 |
| Financing Cash Flow | $5 | $46,744 | $46,744 | $46,769 | $3 |
| Beginning Cash Position | 45,686 | 8,075 | 8,075 | 8,075 | 8,075 |
| End Cash Position | 42,669 | 45,686 | 47,455 | 49,224 | 5,603 |
| Net Cash Flow | $-3,017 | $37,611 | $39,381 | $41,150 | $-2,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,022 | -9,132 | -7,363 | -5,619 | -2,475 |
| Free Cash Flow | -3,022 | -9,132 | -7,363 | -5,619 | -2,475 |